{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T08:04:52Z","timestamp":1779955492658,"version":"3.53.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["21H02931"],"award-info":[{"award-number":["21H02931"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jto.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thoracic Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtho.2025.08.022","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:41:18Z","timestamp":1756946478000},"page":"135-149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Translational Analysis of NSD3 Gene Amplification in Lung Squamous Cell Carcinoma: Clinical and Prognostic Insights From Histopathologic Analysis of Patient Samples"],"prefix":"10.1016","volume":"21","author":[{"given":"Shugo","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Taki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayako","family":"Ura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoko","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Miyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenta","family":"Tane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Samejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiju","family":"Aokage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Wakabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Sasahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiko","family":"Nagamine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kojima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Sakashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuo","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Takamochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genichiro","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtho.2025.08.022_bib1","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jtho.2025.08.022_bib2","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/cncr.34757","article-title":"Targeted therapy for lung cancer: beyond EGFR and ALK","volume":"129","author":"Herrera-Ju\u00e1rez","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.jtho.2025.08.022_bib3","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/JTO.0b013e31827690b5","article-title":"How sensitive are epidermal growth factor receptor-tyrosine kinase inhibitors for squamous cell carcinoma of the lung harboring EGFR gene-sensitive mutations?","volume":"8","author":"Hata","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2025.08.022_bib4","doi-asserted-by":"crossref","first-page":"49680","DOI":"10.18632\/oncotarget.17915","article-title":"Efficacy of epidermal growth factor receptor-tyrosine kinase inhibitors for lung squamous carcinomas harboring EGFR mutation: a multicenter study and pooled analysis of published reports","volume":"8","author":"Liu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jtho.2025.08.022_bib5","doi-asserted-by":"crossref","first-page":"62ra93","DOI":"10.1126\/scitranslmed.3001451","article-title":"Frequent and focal FGFR1 amplification associates with therapeutically tractable FGFR1 dependency in squamous cell lung cancer","volume":"2","author":"Weiss","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jtho.2025.08.022_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0020351","article-title":"Inhibitor-sensitive FGFR1 amplification in human non-small cell lung cancer","volume":"6","author":"Dutt","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jtho.2025.08.022_bib7","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1038\/modpathol.2012.102","article-title":"Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer","volume":"25","author":"Schildhaus","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2025.08.022_bib8","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1097\/JTO.0b013e31826aed28","article-title":"FGFR1 amplification in squamous cell carcinoma of the lung","volume":"7","author":"Heist","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2025.08.022_bib9","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1200\/JCO.2012.43.8622","article-title":"Fibroblast growth factor receptor 1 gene amplification is associated with poor survival and cigarette smoking dosage in patients with resected squamous cell lung cancer","volume":"31","author":"Kim","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2025.08.022_bib10","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.1038\/bjc.2014.229","article-title":"Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer","volume":"110","author":"Cihoric","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jtho.2025.08.022_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00428-014-1634-2","article-title":"FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer","volume":"465","author":"Seo","year":"2014","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jtho.2025.08.022_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2014.11.009","article-title":"FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis","volume":"87","author":"Jiang","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jtho.2025.08.022_bib13","doi-asserted-by":"crossref","first-page":"6658","DOI":"10.1158\/1078-0432.CCR-12-2694","article-title":"Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models","volume":"18","author":"Zhang","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jtho.2025.08.022_bib14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1158\/2159-8290.CD-12-0210","article-title":"FGFR genetic alterations predict for sensitivity to NVP-BGJ398, a selective pan-FGFR inhibitor","volume":"2","author":"Guagnano","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtho.2025.08.022_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/cddiscovery.2015.49","article-title":"FGFR1 inhibition in lung squamous cell carcinoma: questions and controversies","volume":"1","author":"Weeden","year":"2015","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.jtho.2025.08.022_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41586-020-03170-y","article-title":"Elevated NSD3 histone methylation activity drives squamous cell lung cancer","volume":"590","author":"Yuan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.jtho.2025.08.022_bib17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/s43018-022-00416-8","article-title":"Multimodal integration of radiology, pathology and genomics for prediction of response to PD-(L)1 blockade in patients with non-small cell lung cancer","volume":"3","author":"Vanguri","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.jtho.2025.08.022_bib18","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1007\/s12282-023-01507-9","article-title":"Histological spatial analysis on the induction of PD-L1+ macrophages by CD8+ T cells at the marginal microenvironment of triple-negative breast cancer","volume":"30","author":"Suzuki","year":"2023","journal-title":"Breast Cancer"},{"key":"10.1016\/j.jtho.2025.08.022_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/s41467-023-35784-x","article-title":"Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors","volume":"14","author":"Chen","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtho.2025.08.022_bib20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3390\/cancers15020366","article-title":"Prognostic value of CD8+ lymphocytes in hepatocellular carcinoma and perineoplastic parenchyma assessed by interface density profiles in liver resection samples","volume":"15","author":"Stulpinas","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2025.08.022_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2024.114184","article-title":"Prognostic value of the international association for the study of lung cancer grading system and its association with the tumor microenvironment in stage I EGFR-muted lung adenocarcinoma","volume":"207","author":"Kubota","year":"2024","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jtho.2025.08.022_bib22","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/his.15356","article-title":"Ki-67 evaluation using deep-learning model-assisted digital image analysis in breast cancer","volume":"86","author":"Matsumoto","year":"2025","journal-title":"Histopathology"},{"key":"10.1016\/j.jtho.2025.08.022_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.jtho.2025.08.022_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtho.2025.08.022_bib25","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2016.69.4836","article-title":"HER2 testing and clinical decision making in gastroesophageal adenocarcinoma: guideline from the College of American Pathologists, American Society for Clinical Pathology, and the American Society of Clinical Oncology","volume":"35","author":"Bartley","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2025.08.022_bib26","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.2018.77.8738","article-title":"Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology\/College of American Pathologists clinical practice guideline focused update","volume":"36","author":"Wolff","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtho.2025.08.022_bib27","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/modpathol.2011.49","article-title":"SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer","volume":"24","author":"Wilbertz","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jtho.2025.08.022_bib28","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3892\/ijo.2014.2742","article-title":"Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma","volume":"46","author":"Iijima","year":"2015","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jtho.2025.08.022_bib29","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.3892\/ol.2016.5065","article-title":"Expression and significance of SOX2 in non-small cell lung carcinoma","volume":"12","author":"Ying","year":"2016","journal-title":"Oncol Lett"},{"key":"10.1016\/j.jtho.2025.08.022_bib30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1159\/000516444","article-title":"The prognostic value of sex-determining region Y-Box 2 and CD8+ tumor-infiltrating lymphocytes in limited-stage small-cell lung cancer","volume":"99","author":"Lee","year":"2021","journal-title":"Oncology"},{"key":"10.1016\/j.jtho.2025.08.022_bib31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jtho.2016.01.015","article-title":"The role of tumor-infiltrating lymphocytes in development, progression, and prognosis of non-small cell lung cancer","volume":"11","author":"Bremnes","year":"2016","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.jtho.2025.08.022_bib32","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.21037\/jtd-19-3414a","article-title":"Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer","volume":"12","author":"Schulze","year":"2020","journal-title":"J Thorac Dis"},{"key":"10.1016\/j.jtho.2025.08.022_bib33","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/s41419-021-04205-6","article-title":"Elevated expression of nuclear receptor-binding SET domain 3 promotes pancreatic cancer cell growth","volume":"12","author":"Sun","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.jtho.2025.08.022_bib34","doi-asserted-by":"crossref","first-page":"10961","DOI":"10.1002\/cam4.5774","article-title":"NSD3, a member of nuclear receptor-binding SET domain family, is a potential prognostic biomarker for pancreatic cancer","volume":"12","author":"Xiong","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtho.2025.08.022_bib35","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbrc.2010.06.119","article-title":"The NSD3L histone methyltransferase regulates cell cycle and cell invasion in breast cancer cells","volume":"398","author":"Zhou","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jtho.2025.08.022_bib36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1158\/0008-5472.CAN-20-0360","article-title":"NSD3-induced methylation of H3K36 activates NOTCH signaling to drive breast tumor initiation and metastatic progression","volume":"81","author":"Jeong","year":"2021","journal-title":"Cancer Res"},{"key":"10.1016\/j.jtho.2025.08.022_bib37","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.2147\/OTT.S191732","article-title":"Downregulation of NSD3 (WHSC1L1) inhibits cell proliferation and migration via ERK1\/2 deactivation and decreasing CAPG expression in colorectal cancer cells","volume":"12","author":"Yi","year":"2019","journal-title":"Onco Targets Ther"},{"key":"10.1016\/j.jtho.2025.08.022_bib38","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.3390\/cancers14204997","article-title":"Dissecting the immunological profiles in NSD3-amplified LUSC through integrative multi-scale analyses","volume":"14","author":"Xu","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtho.2025.08.022_bib39","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.molcel.2015.10.033","article-title":"NSD3-short is an adaptor protein that couples BRD4 to the CHD8 chromatin remodeler","volume":"60","author":"Shen","year":"2015","journal-title":"Mol Cell"},{"key":"10.1016\/j.jtho.2025.08.022_bib40","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.str.2016.04.019","article-title":"Structural mechanism of transcriptional regulator NSD3 recognition by the ET domain of BRD4","volume":"24","author":"Zhang","year":"2016","journal-title":"Structure"}],"container-title":["Journal of Thoracic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086425010366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556086425010366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T07:36:55Z","timestamp":1779953815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556086425010366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1556086425010366"],"URL":"https:\/\/doi.org\/10.1016\/j.jtho.2025.08.022","relation":{},"ISSN":["1556-0864"],"issn-type":[{"value":"1556-0864","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Translational Analysis of NSD3 Gene Amplification in Lung Squamous Cell Carcinoma: Clinical and Prognostic Insights From Histopathologic Analysis of Patient Samples","name":"articletitle","label":"Article Title"},{"value":"Journal of Thoracic Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtho.2025.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}